Logo CICANCER
Intranet Colaborate

Old CIC Events

Poster presentation of the master's degree in Biology and Clinic of Cancer 13/04/2023

Poster presentation of the master's degree in Biology and Clinic of Cancer

Master's students —

N6-ADENOSINE METHYLTRANSFERASE COMPLEX REGULATOR ZC3H13 DELETION AS MALIGNANT PROGNOSIS FACTOR IN PROSTATE CANCER 30/03/2023

N6-ADENOSINE METHYLTRANSFERASE COMPLEX REGULATOR ZC3H13 DELETION AS MALIGNANT PROGNOSIS FACTOR IN PROSTATE CANCER

Óscar Monteagudo — Epitranscriptomic and Cancer Lab, Centro de Investigación del Cáncer (CIC)

Functions of METTL3 in stem cells and cancer 23/03/2023

Functions of METTL3 in stem cells and cancer

Francesca Aguilo — Umea University, Sweden

Specific killing of BRCA1-deficient cancer cells by depletion of EXO1 16/03/2023

Specific killing of BRCA1-deficient cancer cells by depletion of EXO1

Haico van Attikum — Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands

RAS-p110a signalling controls macrophage-derived inflammatory response by favouring transendothelial migration and phagocytic capacity. 09/03/2023

RAS-p110a signalling controls macrophage-derived inflammatory response by favouring transendothelial migration and phagocytic capacity.

Alejandro Rosell Jiménez — Centro de Investigación del Cáncer (CSIC-USAL), Salamanca

Connecting myeloid cell metabolism and function 02/03/2023

Connecting myeloid cell metabolism and function

David Sancho Madrid — Centro Nacional de Investigaciones Cardiovasculares de Madrid

AHR adjusts senescence and stemness: impact in tissue regeneration and tumor progression 23/02/2023

AHR adjusts senescence and stemness: impact in tissue regeneration and tumor progression

Pedro M. Fernández Salguero — Universidad de Extremadura, Badajoz.

ctDNA in cancer care 16/02/2023

ctDNA in cancer care

Elza de Bruin — Director Translational Medicine, AstraZeneca, Cambridge, UK

Metabolic Reprogramming in Cancer Progression: Making the difference 09/02/2023

Metabolic Reprogramming in Cancer Progression: Making the difference

Patricia Altea Manzano — Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Belgium

Spatial synthetic lethality- a new approach to treat B cell lymphoma (?) 03/02/2023

Spatial synthetic lethality- a new approach to treat B cell lymphoma (?)

Ingo Ringshausen — University of Cambridge, Wellcome–MRC Cambridge Stem Cell Institute

Self-organization of MAPK Signaling Dynamics in the Epithelium 02/02/2023

Self-organization of MAPK Signaling Dynamics in the Epithelium

Olivier Pertz — Institute of Cell Biology, University of Bern (Swizerland)

Cell-of-origin as a route to understand the onset of aggressive prostate tumours 01/02/2023

Cell-of-origin as a route to understand the onset of aggressive prostate tumours

Esther Baena — Cancer Research UK Manchester Institute, University of Manchester